Publication: Resolution and identification of scalemic caged xanthones from the leaf extract of Garcinia propinqua having potent cytotoxicities against colon cancer cells
Issued Date
2018-01-01
Resource Type
ISSN
18736971
0367326X
0367326X
Other identifier(s)
2-s2.0-85031744074
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Fitoterapia. Vol.124, (2018), 34-41
Suggested Citation
Teerayut Sriyatep, Cholpisut Tantapakul, Raymond J. Andersen, Brian O. Patrick, Stephen G. Pyne, Chatchai Muanprasat, Sawinee Seemakhan, Suparerk Borwornpinyo, Surat Laphookhieo Resolution and identification of scalemic caged xanthones from the leaf extract of Garcinia propinqua having potent cytotoxicities against colon cancer cells. Fitoterapia. Vol.124, (2018), 34-41. doi:10.1016/j.fitote.2017.10.009 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/47339
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Resolution and identification of scalemic caged xanthones from the leaf extract of Garcinia propinqua having potent cytotoxicities against colon cancer cells
Abstract
© 2017 A new scalemic 8,8a-dihydro caged xanthone (1) was isolated from the leaf extract of Garcinia propinqua. Five other known natural products, the three caged xanthones (2, 5 and 6) and the two neocaged xanthones, (3 and 4) were also isolated as scalemic mixtures. Their structures were characterized by spectroscopic methods. The enantiomeric ratios (er) of compounds 1–6 ranged from 1:0.7 to 1:0.9. These compounds were also resolved by semipreparative chiral HPLC. The absolute configurations of (+)-2 and (+)-3 were determined by single-crystal X-ray diffraction analysis using Cu Kα radiation while the absolute configurations of the other compounds were determined by comparisons of their ECD spectra. Compounds (−)-4, (+)-4, (−)-5, (+)-5, and (−)-6 showed potent cytotoxicities against a colon cancer cell line HCT116 with IC50 values of 2.60, 7.02, 1.47, 3.37, and 4.14 μM, respectively, which were better than the standard control doxorubicin (IC50 9.74 μM).